MDXG News and Press, MiMedx Group Inc From 03/03/21

MARIETTA, Ga., March 03, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that management will be participating in the following ...

MARIETTA, Ga., March 02, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that it will report financial results for the fourth qu...

My former 45-stock portfolio gets a haircut down to 37 stocks as I de-diversify in favor of bigger and riskier bets with volatility on the rise. Global Ship Lease is the new major position in my portfolio with earnings in the first week of March and upside potential all year long in m...

MARIETTA, Ga., Feb. 10, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Pet...

The Welsh portfolio outperformed the S&P 500 over the first month of 2021. Added a small amount of additional risk to my portfolio to potentially seize the current Wall Street Bets and Robinhood volatility. Bitcoin, Virgin Galactic, and soon First Majestic Silver Company give ...

The following slide deck was published by MiMedx Group, Inc. in conjunction with this event. For further details see: MiMedx Group (MDXG) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

The activist investor, Prescience Point has revealed ~8% stake in MiMedx Group ([[MDXG]] +0.8%) as indicated by regulatory filing, which represents over 8.7M shares.The investor also says that after completing Phase 2b Knee OA trial evaluating dHACM injection, the company should consider...

MARIETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Pet...

MARIETTA, Ga., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Dr....

Persistent and sustained institutional buying in MiMedx should not be ignored as heavy hitters position themselves for key knee osteoarthritis data in 2021. Sales and revenue growth after two years of floundering could cause additional explosive upside. If you are looking for a de...